Kevin J. Anstrom

University of North Carolina at Chapel Hill

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 45 papers. Top paper: “Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction”.

Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction

JAMA(2020)10.1001/jama.2020.15922

N/A

5.3DataRank · unranked

278 citations

Carolyn S.P. Lam, Kevin J. Anstrom, Justin A. Ezekowitz, Adrian F. Hernandez, Christopher M. O’Connor +14 more

Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT

Journal of the American College of Cardiology(2020)10.1016/j.jacc.2020.05.061

N/A

3.9DataRank · unranked

88 citations

Brian Olshansky, Daniel B. Mark, Jill Anderson, George Johnson, Anne S. Hellkamp +9 more

Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease

JAMA Cardiology(2023)10.1001/jamacardio.2023.2595

N/A

2.1DataRank · unranked

97 citations

Michael G. Nanna, Michelle D. Kelsey, Eric Yow, Daniel B. Mark, Manesh R. Patel +95 more

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

The Lancet(2025)10.1016/s0140-6736(25)01665-4

N/A

1.3DataRank · unranked

71 citations

Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash, Marc P. Bonaca, Maria Borentain +94 more

Tolerability of Sacubitril/Valsartan in Patients With Advanced Heart Failure

JACC Heart Failure(2022)10.1016/j.jchf.2022.04.013

N/A

1.3DataRank · unranked

34 citations

Michael M. Givertz, Randall C. Starling, Steven E. McNulty, Kevin J. Anstrom, Patrice Desvigne‐Nickens +4 more

Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial

Circulation Heart Failure(2022)10.1161/circheartfailure.121.009337

N/A

1.1DataRank · unranked

43 citations

Amanda Stebbins, Vojtěch Melenovský, Nancy K. Sweitzer, Martín Cowie, Josef Stehlik +15 more

Test-to-Stay After Exposure to SARS-CoV-2 in K–12 Schools

PEDIATRICS(2022)10.1542/peds.2021-056045

N/A

0.809DataRank · unranked

18 citations

Daniel K. Benjamin, Tara K. Mann, Alex Fist, Hwasoon Kim, Laura Edwards +16 more

Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial

Circulation(2023)10.1161/circulationaha.123.064842

N/A

0.649DataRank · unranked

23 citations

Eric J. Velazquez, Kevin J. Anstrom, Robert M. Clare, Tracy A. DeWald, Mitchell A. Psotka +12 more

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

The Lancet(2025)10.1016/s0140-6736(25)01682-4

N/A

0.550DataRank · unranked

38 citations

Christopher M. O’Connor, Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash +84 more

Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung Disease

American Journal of Respiratory and Critical Care Medicine(2023)10.1164/rccm.202308-1357oc

N/A

0.505DataRank · unranked

28 citations

John S. Kim, Shwu‐Fan Ma, Piyush Ranjan, Promi Das, Jay H. Lipinski +10 more

Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19

medRxiv(2022)10.1101/2022.09.22.22280245

N/A

0.464DataRank · unranked

9 citations

Eyal Kedar, Kevin J. Anstrom, Matthew W. McCarthy, Emily R. Ko, Patricia Segura Nunez +38 more

Torsemide Versus Furosemide After Discharge in Patients Hospitalized With Heart Failure Across the Spectrum of Ejection Fraction: Findings From TRANSFORM-HF

Circulation Heart Failure(2024)10.1161/circheartfailure.123.011246

N/A

0.436DataRank · unranked

8 citations

Stephen J. Greene, Robert J. Mentz, Uchechukwu Ikeaba, Daniel Wojdyla, Kevin J. Anstrom +6 more

Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial

Journal of the American Heart Association(2023)10.1161/jaha.122.027871

N/A

0.434DataRank · unranked

17 citations

Yanhong Li, A Silverstein, Andrea M. Russo, Jeanne E. Poole, Melanie R. Daniels +8 more

Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2)

American Heart Journal(2024)10.1016/j.ahj.2024.04.005

N/A

0.413DataRank · unranked

6 citations

Regina M. Santella, Bonnie R. Joubert, Zhen Huang, Yuliya Lokhnygina, Francisco Ujueta +14 more

Closing the Evidence Gap in Interstitial Lung Disease. The Promise of Real-World Data

American Journal of Respiratory and Critical Care Medicine(2019)10.1164/rccm.201807-1209pp

N/A

0.345DataRank · unranked

9 citations

Kevin J. Anstrom, Atul Janardhan Butte, Carlos Iribarren, Brett Ley, Fernando J. Martinez +4 more

Mosaic loss of chromosome Y in blood is associated with male susceptibility for idiopathic pulmonary fibrosis

Communications Medicine(2025)10.1038/s43856-025-00966-9

N/A

0.345DataRank · unranked

9 citations

Nicholas W. Chavkin, Jonatan Halvardson, Mark C. Thel, Jonas Mattisson, John S. Kim +8 more

The design and rationale of the Biomarkers for Evaluating Spine Treatments trial: a sequential multiple assignment randomized trial

Pain Medicine(2025)10.1093/pm/pnaf032

N/A

0.336DataRank · unranked

8 citations

Kelly S. Barth, Kevin M. Bell, Amber K Brooks, Andrea L. Chadwick, Cameron A. Gunn +62 more

On-Treatment Analysis of Torsemide Versus Furosemide for Patients Hospitalized for Heart Failure: A Post-Hoc Analysis of TRANSFORM-HF

European Journal of Heart Failure(2024)10.1002/ejhf.3293

N/A

0.296DataRank · unranked

4 citations

Robert J. Mentz, Robert M. Clare, Daniel Wojdyla, Kevin J. Anstrom, Eric L. Eisenstein +10 more

Clinical Implications of Negatively Adjudicated Heart Failure Events: Data From the VICTORIA Study

Circulation(2023)10.1161/circulationaha.122.062055

N/A

0.292DataRank · unranked

6 citations

Rebecca North, Hillary Mulder, W. Schuyler Jones, Kevin J. Anstrom, Mahesh J. Patel +9 more

Classification of Heart Failure Events by Severity: Insights From the VICTORIA Trial

Journal of Cardiac Failure(2023)10.1016/j.cardfail.2023.04.015

N/A

0.278DataRank · unranked

4 citations

Rebecca North, Hillary Mulder, W. Schuyler Jones, Kevin J. Anstrom, Mahesh J. Patel +8 more

Efficacy of infliximab, abatacept, and cenicriviroc for the treatment of adults hospitalized with COVID-19 pneumonia

International Journal of Infectious Diseases(2024)10.1016/j.ijid.2024.107168

N/A

0.241DataRank · unranked

4 citations

J. Wang, Kevin J. Anstrom, Lisa M. LaVange, Jun Wen, Samuel A. Bozzette +2 more

The statistical design and analysis of pandemic platform trials: Implications for the future

Journal of Clinical and Translational Science(2024)10.1017/cts.2024.514

N/A

0.165DataRank · unranked

2 citations

Matthew Shotwell, Kevin J. Anstrom, Scott Berry, Erica Brittain, Frank E. Harrell +13 more

High-risk subgroups were not identified to benefit from thromboprophylaxis after hospitalization for COVID-19

Research and Practice in Thrombosis and Haemostasis(2024)10.1016/j.rpth.2024.102417

N/A

0.104DataRank · unranked

1 citations

Taeim Kwon, Raj S. Kasthuri, Lana Wahid, Peter Miller, Kimberly Enders +5 more

TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine(2024)10.1164/rccm.202312-2224le

N/A

0DataRank · unranked

8 citations

Kristin Berger, John S. Kim, Will Simmons, Shwu‐Fan Ma, Robert J. Kaner +11 more

Evaluating registry-based trial economics: Results from the STRESS clinical trial

Contemporary Clinical Trials Communications(2024)10.1016/j.conctc.2024.101257

N/A

0DataRank · unranked

4 citations

Kevin D. Hill, Nancy Wood, Jerry Kirchner, Kevin J. Anstrom, Christopher B. Granger +9 more

The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and Design

European Journal of Heart Failure(2024)10.1002/ejhf.3453

N/A

0DataRank · unranked

28 citations

Stefan James, Adam D. DeVore, Kevin J. Anstrom, Marat Fudim, Keith D. Aaronson +17 more

The Back Pain Consortium (BACPAC) Research Program: Structure, Research Priorities, and Methods

Pain Medicine(2023)10.1093/pm/pnac202

N/A

0DataRank · unranked

32 citations

Jeffrey C. Lotz, Matthew A. Psioda, Timothy S. Carey, Daniel J. Clauw, Sharmila Majumdar +35 more

The trial to assess chelation therapy 2 (TACT2): Rationale and design

American Heart Journal(2022)10.1016/j.ahj.2022.05.013

N/A

0DataRank · unranked

26 citations

Kevin J. Anstrom, Ana Navas‐Acién, Robin Boineau, Hwasoon Kim, Yves Rosenberg +16 more

ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic

Journal of Clinical and Translational Science(2024)10.1017/cts.2024.1

N/A

0DataRank · unranked

1 citations

Kevin J. Anstrom, Christina E. Barkauskas, Samuel M. Brown, Eric S. Daar, William A. Fischer +16 more

Integrating randomized and observational studies to estimate optimal dynamic treatment regimes

Biometrics(2024)10.1093/biomtc/ujae046

N/A

0DataRank · unranked

0 citations

Kevin J. Anstrom, Donglin Zeng, Anna Batorsky

The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT‐HFpEF): Rationale and design

UNC Libraries(2024)10.17615/aqvd-ae34

N/A

0DataRank · unranked

0 citations

Tymon Pol, Patric Karlström, Michael Fu, Ulf Dahlström, Adam D. DeVore +17 more

ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic

UNC Libraries(2024)10.17615/wtgx-4h88

N/A

0DataRank · unranked

0 citations

Mahesh Parmar, Roger Paredes, Kevin J. Anstrom, Stacey J. Adam, Seema Nayak +16 more

Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum

European Journal of Heart Failure(2022)10.1002/ejhf.2720

N/A

0DataRank · unranked

36 citations

Muhammad Usman, Kevin J. Anstrom, Robert O. Blaustein, Marc P. Bonaca, Justin A. Ezekowitz +14 more

Reply

JACC Heart Failure(2021)10.1016/j.jchf.2021.05.018

N/A

0DataRank · unranked

2 citations

Eric J. Velazquez, Kevin J. Anstrom, Eric L. Eisenstein, Robert J. Mentz, Stephen J. Greene

Polypharmacy in Palliative Care for Advanced Heart Failure: The PAL-HF Experience

Journal of Cardiac Failure(2021)10.1016/j.cardfail.2021.08.021

N/A

0DataRank · unranked

8 citations

James A. Tulsky, Brystana G. Kaufman, Robert M. Clare, Kevin J. Anstrom, Daniel B. Mark +8 more

TransRadial Education and Therapeutics (TREAT): Shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: A report from the Cardiac Safety Research Consortium

UNC Libraries(2020)10.17615/tde1-ca14

N/A

0DataRank · unranked

0 citations

Mitchell W. Krucoff, Alice K. Jacobs, Connie N. Hess, Jean‐Philippe Collet, Benjamin C. Eloff +17 more

Building community through data: the value of a researcher driven open science ecosystem

Pain Medicine(2025)10.1093/pm/pnaf003

N/A

0DataRank · unranked

7 citations

Carla Bann, Emine O. Bayman, Maria T. Chao, Georgene W. Hergenroeder, Charles Knott +13 more

Development of clinical research networks in rural America: Our experience from the Accelerating COVID-19 Therapeutic Interventions and Vaccines-1 trial

Journal of Clinical and Translational Science(2025)10.1017/cts.2025.10208

N/A

0DataRank · unranked

1 citations

Dima Dandachi, Alexis Bryant, Kevin J. Anstrom, William G. Powderly, Eyal Kedar

Assessing Benefit in Heart Failure Patients with Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk Stratification

medRxiv(2025)10.1101/2025.04.03.25325054

N/A

0DataRank · unranked

0 citations

Sarah Rathwell, Devan V. Mehrotra, Stefano Corda, Ciaran J. McMullan, Carolyn S.P. Lam +13 more

Extended Thromboprophylaxis in Patients Hospitalized with COVID-19 at Time of Discharge is Not Associated with Improvement in Quality of Life

The American Journal of Medicine(2025)10.1016/j.amjmed.2025.06.003

N/A

0DataRank · unranked

0 citations

Taeim Kwon, Lisa Baumann Kreuziger, Raj S. Kasthuri, Peter Miller, Tracy Y. Wang +3 more

Clinical Endpoints in Pragmatic Heart Failure Trials: From Data Collection to Clinical Endpoint Classification

ESC Heart Failure(2025)10.1002/ehf2.15366

N/A

0DataRank · unranked

0 citations

Harriette G.C. Van Spall, W. Schuyler Jones, Marat Fudim, Robert J. Mentz, Kevin J. Anstrom +9 more

Baseline characteristics of participants in the Biomarkers for Evaluating Spine Treatments clinical trial: a sequential multiple assignment randomized trial for chronic low back pain

Pain Medicine(2025)10.1093/pm/pnaf073

N/A

0DataRank · unranked

0 citations

Kelly S. Barth, Kevin M. Bell, Amber K Brooks, Andrea L. Chadwick, Annika Cleven +82 more

Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization

UNC Libraries(2025)10.17615/vme9-c859

N/A

0DataRank · unranked

0 citations

Lisa Baumann Kreuziger, Annie Pennella, Nancy L. Shapiro, Alexandra Weissman, Deborah Siegal +25 more

SARS-CoV-2 N protein and anti-spike serologies: insights into COVID-19 disease severity and mortality—a secondary analysis of the ACTIV-1 trial

Therapeutic Advances in Infectious Disease(2025)10.1177/20499361251333617

N/A

0DataRank · unranked

0 citations

Kimi Enders, Huimin Wu, Luis Parra-Rodriguez, Christopher Palma, Katy Saliba +6 more

Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve

American Heart Journal(2020)10.1016/j.ahj.2020.06.014

N/A

0DataRank · unranked

82 citations

Tracy Y. Wang, Renato D. Lópes, Alma Chavez, Brittanny Boyer, Hwasoon Kim +12 more